4527.T
ROHTO PHARMACEUTICAL CO.,LTD.
プライム · 医薬品 · 医薬品 · JP
JPY 3,057.00
+0.59%Year over year
Reported trailing growth
- Revenue
- +11.4%
- EBITDA
- —
- EBIT
- +5.6%
- EPS
- +11.5%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -0.9%
- EBITDA
- —
- EPS
- -3.6%
Three-year CAGR
- Revenue
- +12.9%
- EBITDA
- +10.9%
- EBIT
- +6.6%
- Net income
- +9.1%
- EPS
- +9.4%
- Free cash flow
- +17.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026